Track the news on our web site as we have almost started the countdown to the very first public release of our workflow system "From genome to target" for automatized search of new therapeutic targets.
Come and join us on the grand opening of Biosoft's new office in Skolkovo Technopark on April 21st! You will find interesting lectures on bioinformatics, workshops and a hakaton on search for personalized biomarkers and drug targets on real patient's data.
Join us on April 13th if you are interested in molecular medicine and drug development, as we are going to give a webinar on the basic approach for searching for new drug targets and biomarkers.
We will be searching for colorectal cancer liver metastasis treatment in cooperation with our German colleagues, funded by BMBF in this mutual German-Russian grant initiative.
We are proud to announce the workflow system "From genome to target" will be launched in summer 2017. With the support and financing from Fund Skolkovo the Biosoft's team is currently finishing the development of this unique tool for biomedical data analysis.
LLC “BIOSOFT.RU” took part in the II National Congress on Regenerative Medicine. Due to the organizers of the congress and to the support of Russian Ministry of Industry and Trade, the company’s representatives were able to take part in the exhibition and to make an oral report on one of the conference’s sessions.
LLC “BIOSOFT.RU” will attend the 2nd International conference and exhibition FIZTEH-MED 2015 conducted under the auspices of the Ministry of Industry and Trade of the Russian Federation
The Biosoft project was chosen as a finalist in the InBioMed 2014 competition.
Starting from February 2013 Biosoft is ready to execute any of the biomedical data analysis services that are listed in the "Products and Services" tab.
An online workflow for data analysis has been developed within the bounds of the Biosoft project